Creo Medical Group sales momentum continuing into 2022
The US saw a record month for cases performed using Speedboat Inject
Company
Creo Medical Group PLC
LON:CREO
Creo Medical Group PLC is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. The company's vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive. Kamaptive is a seamless, intuitive integration of multi-modal energy sources, optimised to dynamically adapt to patient tissue during procedures such as resection, dissection, coagulation and ablation of tissue.
113 stories · page 5 of 6
Creo says founder and CTO wins 'innovator of the year' award
Hancock has over 20 years’ experience in medical device development
Creo Medical hails success of Albyn acquisition as it pays first tranche of earn out
“That the Albyn team have successfully fulfilled the acquisition earn-out criteria shows that they are performing well in what has been a challenging period,” said chief executive Craig Gulliford
Archive
Small cap movers: Creo Medical Group on the crest of a wave after flagging strong demand for Speedboat Inject
A look at some of the major movers this week in the small caps universe
Creo Medical leaps 9% as sales set to exceed expectations
In a trading update, it told investors that 2022 had begun ‘positively’
Creo Medical signs non-binding terms with a number of potential partners
The company has a strategy based on three pillars, one of which is finding partners in adjacent markets for its breakthrough Kamaptive technology
Creo Medical delivering the next generation of minimally invasive surgical technology
Creo is in the process of commercialising advanced energy surgical tools
Archive
Proactive News Headlines: Diversified Energy Company, Nuformix, Quantum Blockchain Technologies …
A glance at some of the day's highlights from the Proactive Newswire.
Creo Medical acquires component supplier as part of its 'build, buy, partner strategy'
Aber Electronics is a manufacturer and designer of power amplifiers and radio frequency products
Creo Medical revenues driven forward by Albyn
Cenkos upped its estimate for revenues for 2021 by 7.5%
Creo Medical Group makes 'strategic and operational progress'
“We are very optimistic for the continued progress of the business throughout 2021 and into 2022," said CEO Craig Guildford
Creo Medical says US FDA-approved MicroBlate Fine was successfully used to treat pancreatic cancer patient
“The outcome of the procedure was a success, with subsequent follow up scans not only showing no return of the tumour, but also an absence of any obvious scar tissue,” said chief executive Craig Gulliford
Archive
Small Cap Wrap - Sareum Holdings, Creo Medical Group, Versarien and more...
Upon Admission to AIM, Nightcap will acquire The London Cocktail Club Limited (the "London Cocktail Club"), which is an award winning independent operator of ten individually themed cocktail bars in nine London locations and one location in
Creo Medical lands £2mln loan to fund development of sterlisation technology that could help combat coronavirus
"The Cool Plasma technology was one of Creo's very early projects, which was originally focused on hand sanitisation,” explained the medical devices specialist’s chief technology officer, Professor Chris Hancock
Archive
React Group jumps on share placing amid high cleaning services demand
A look at Wednesday's major movers on the London Stock Exchange
Investments and investor services
FTSE 100 closes in positive territory, boosted by better-than-expected US March jobs figures as Brexit uncertainty continues
"Small gains are the order of the day aside from in the UK, where again sterling weakness has allowed the FTSE 100 to register some reasonable gains," says Christ Beauchamp from IG
Archive
Pinstickers will pile onto the Grand National, but GVC update should provide more on the Cheltenham impact
Aside from the trading news from Ladbrokes Coral bookmaker's owner GVC, the main focus for the Day Ahead will be the March US non-farm payrolls data
Archive
US jobs to provide main focus, though UK PMIs still key as Brexit SNAFU continues
Aside from the UK and US data - and Brexit - corporate news in the week ahead will include updates from blue-chip budget airline easyjet and Ladbrokes Coral owner GVC Holdings